In 2017, the World Health Organization recognized Togo for eliminating lymphatic filariasis as a public problem in the country. Togo is the first country in Africa to receive WHO validation for elimination of the disease.
Togo national onchocerciasis program has reinforced its lab capacity and made significant efforts to analyze and clear all the 13951 laboratory backlog samples, paving the way to completing all the impacts surveys for stopping MDA in FY22-FY23.
Togo is one of the first countries to conduct annual community-based mass drug administration (MDA) for soil-transmitted helminths (STH) and schistosomiasis (SCH) at the sub-district level. Togo conducted its second re-assessment survey in 2021 among 93 sub-districts to review the impact of multiple rounds of high coverage MDA.
Togo was the second Act West countries to form a SCH expert committee in 2021.
Togo was also selected by the Task Force for Global Health to conduct a SCH oversampling survey in 2022, both of which will provide additional data for the country to re-assess its treatment strategy going forward.
Standard Disease-Specific Indicators as of FY20
FY20 is October 2019 through September 2020